Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Brazil
/
Pharmaceuticals & Biotech
Create a narrative
Blau Farmacêutica Community
BOVESPA:BLAU3 Community
1
Narratives
written by author
0
Comments
on narratives written by author
6
Fair Values set
on narratives written by author
Create a narrative
Blau Farmacêutica
Popular
Undervalued
Overvalued
Community Investing Ideas
Blau Farmacêutica
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Latin America Expansion And R&D Will Unlock New Markets
Key Takeaways Strategic LatAm expansion and international partnerships are set to boost revenue and expand market share across multiple countries. Investment in high-value biotechnological products and operational efficiencies are key to increasing profit margins and financial strength.
View narrative
R$16.53
FV
12.5% undervalued
intrinsic discount
11.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
9 days ago
author updated this narrative
Your Valuation for
BLAU3
BLAU3
Blau Farmacêutica
Your Fair Value
R$
Current Price
R$14.46
88.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
3b
2015
2018
2021
2024
2025
2027
2030
Revenue R$3.0b
Earnings R$448.1m
Advanced
Set Fair Value